Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04907799 · ClinicalTrials.gov registry record · NA
Daily Caloric Restriction in ADPKD
A NA study of Overweight and Obesity and Autosomal Dominant Polycystic Kidney, sponsored by University of Colorado, Denver.
- Active
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT04907799: Active NA study of Overweight and Obesity and Autosomal Dominant Polycystic Kidney, sponsored by University of Colorado, Denver.
NCT04907799 is a NA study of Overweight and Obesity and Autosomal Dominant Polycystic Kidney that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 125 participants, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04907799, a NA study of Overweight and Obesity and Autosomal Dominant Polycystic Kidney, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial will determine whether a daily-caloric restriction-based weight loss intervention can slow kidney growth in adults with autosomal dominant polycystic kidney disease who are overweight or obese. The study will also evaluate changes in abdominal fat by magnetic resonance imaging. Blood and fat samples will provide insight into biological changes that may contribute to any observed benefits of the intervention.
Primary Outcome
To assess kidney growth, we will measure height-adjusted total kidney volume by magnetic resonance imaging at baseline and 24 months to determine annual percent change.
Conditions Studied
Interventions
- BEHAVIORAL Daily caloric restriction
- OTHER Standard advice control
Study Locations (1)
Colorado
- University of Colorado - Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2021-11-03 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What the registry record for NCT04907799 still lists
NCT04907799 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (45% lower).
The record links to 2 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Daily caloric restriction is the first listed.
NCT04907799 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04907799 about?
NCT04907799 is a clinical study titled "Daily Caloric Restriction in ADPKD". This clinical trial will determine whether a daily-caloric restriction-based weight loss intervention can slow kidney growth in adults with autosomal dominant polycystic kidney disease who are overweight or obese. The study will also evaluate changes in abdominal fat by magnetic resonance imaging. B...
What is the current status of trial NCT04907799?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2021-11-03. Estimated completion is 2027-06-30.
What conditions does trial NCT04907799 study?
This clinical trial studies the following conditions: Overweight and Obesity, Autosomal Dominant Polycystic Kidney.
What interventions are being tested in trial NCT04907799?
The interventions under investigation include: Daily caloric restriction (BEHAVIORAL), Standard advice control (OTHER).
Who is sponsoring clinical trial NCT04907799?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04907799 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04907799's enrollment target sits among peer trials
125 50th of 115 higher than 65 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI